Composition containing 2′-FL for ameliorating, preventing or treating diseases caused by reduction of dopamine

Inventors: Seong Jin Yu (Miaoli, TW); Kuo Jen Wu (Miaoli, TW); Yun Wang (Miaoli, TW); Chul Soo Shin (Suwon-si, KR); Jong Won Yoon (Seongnam-si, KR); Seon Min Jeon (Daegu, KR); Young Ha Song (Yongin-si, KR); Jong Gil Yoo (Pyeongtaek-si, KR); Ji Eun Kim (Hwaseong-si, KR)

Assignee: ADVANCED PROTEIN TECHNOLOGIES CORP.

A61K31/702 A61P25/16

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 12667582
App. No.: 18/566,456
Granted: Jun 30, 2026
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

Disclosed is a composition containing 2′-FL for ameliorating, preventing or treating diseases caused by reduction of dopamine. 2′-FL has an advantage of effectively preventing or treating diseases caused by a decrease in dopamine by effectively suppressing degeneration of dopaminergic neurons. In particular, the composition of the present invention is effective in preventing, treating, or ameliorating Parkinson's disease caused by reduction of dopamine because it contains 2′-fucosyllactose (2′-FL) as an active ingredient, thereby suppressing the decrease in dopaminergic neurons and exhibiting an effect of improving motor activity.

Claims (4)

1 . A method for ameliorating or treating Parkinson's disease caused by reduction in dopamine, the method comprising:

administering a composition comprising a therapeutically effective amount of 2′-fucosyllactose (2′-FL) to a subject in need thereof.

2 . The method according to claim 1 ,

wherein the subject requires inhibiting a decrease in dopaminergic neurons and improving motor activity.